EGFR and cancer: Receptor tyrosine kinases (RTKs) that respond to the Epidermal Growth Factor (EGF) family of ligands play important roles in development and physiology across metazoa, and dysregulation of EGF receptor (EGFR/ErbB) signaling is associated with several human cancers(Uribe et al. 2021).